EssilorLuxottica e Meta accelerano l’evoluzione degli AI glasses con i nuovi prodotti presentati al Meta Connect

EssilorLuxottica and Meta unveiled Ray-Ban Meta Gen 3 and a new camera-free Ray-Ban Meta Audio line, expanding their AI-glasses portfolio to more than 100 model-and-style combinations by year-end. Gen 3 adds improved battery life, a customizable Meta AI button and 27 color/lens combinations, while Meta's Muse AI agent will initially launch on glasses in the U.S. The companies are expanding retail availability into 10 additional markets and launching Meta Ray-Ban Display in the UK and Canada, with preorders planned for France, Italy and Germany. New FDA-authorized software for adults with mild-to-moderate hearing loss, sold individually or by subscription, is also planned for U.S. introduction by year-end.

Analysis

EL is the cleaner near-term beneficiary because broader style/fit coverage converts AI-glasses demand into optical retail traffic, prescription-lens attachment and higher mix without requiring Meta to prove standalone hardware economics. The camera-free audio line is strategically important: it lowers privacy friction in workplaces and schools while expanding the addressable market to consumers unwilling to wear a camera. That can raise unit velocity, but its lower component content means revenue upside depends on premium lens attach and service conversion rather than volume alone.

For META, the value lies less in initial device revenue than in establishing a persistent, hands-free distribution endpoint for its AI agent. The key 1-3 month catalyst is evidence that availability beyond launch cities produces low return rates and meaningful AI engagement; absent disclosed sell-through, this remains a product-announcement signal rather than an earnings-estimate event. FDA-authorized hearing functionality creates a potentially recurring software/subscription layer, but reimbursement, clinical positioning and regulatory claims will determine whether it becomes material over 6-18 months.

DLB has modest upside through immersive-audio content and certification, but it is unlikely to move consolidated estimates without attach-rate or royalty disclosure. The contrarian risk is that a proliferation of SKUs obscures a constrained supply chain: prescription fulfillment capacity, battery yields and retail staff training can cap conversion precisely as geographic availability expands. Apple (AAPL), Google (GOOGL) and Samsung gain a validated category but face a difficult incumbent advantage: EL controls branded frames, optical distribution and prescription relationships.

The market should resist extrapolating portfolio breadth into a category inflection before management quantifies units, gross margin and repeat usage. Watch for EL optical-store same-store sales acceleration and META Reality Labs loss guidance: strong sell-through accompanied by rising subsidy spend would be strategically positive but financially dilutive.

Key Decisions for Investors

• Maintain/add EL (EL.PA) over META on a 3-6 month horizon; use the next quarterly update to require evidence of optical retail traffic, prescription attachment and stable gross margin. Thesis is falsified if smart-glasses expansion coincides with flat optical comparable sales or incremental margin dilution.
• Do not chase META solely on this launch. Set an alert for disclosed sell-through, return rates, weekly AI usage or a reduction in Reality Labs loss guidance; initiate only if hardware engagement scales without higher-than-expected operating-loss investment. Near-term downside risk is multiple pressure if AI-glasses spending adds to capex and Reality Labs losses.
• Consider a 6-12 month pair: long EL.PA / short a basket proxy of AAPL and GOOGL only after confirmed international sell-through. EL's retail and prescription moat should capture early category monetization; cover if either platform announces a comparable branded optical partnership or EL reports weak attachment/returns.
• Keep DLB on watch rather than position. Upgrade only if Dolby discloses a per-unit royalty or a measurable increase in mobile/device licensing revenue; otherwise the glasses contribution is too small relative to its broader licensing cycle.